Real-time enrollment status for this head and neck cancer clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT05050162 |
| Recruiting Status | Suspended |
| Condition | Head and Neck Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,714 participants |
| Active Locations | 359 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | January 14, 2026 (Jan 14, 2026) |
As of March 2, 2026: Clinical trial NCT05050162 is currently suspended participants. This clinical trial study for head and neck cancer is not currently accepting new participants at 359 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05050162 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 359 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05050162 was last updated Jan 14, 2026 (January 14, 2026). HelloStudys verifies this status automatically.